Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC

Not Applicable

Recruiting

• Conditions: Talar Osteochondral Defect of Ankle; Pain; Arthroscopy
• Interventions: Other: AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)

• Registration Number: NCT03371121
• Lead Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Brief Summary

Aim of the study is to evaluate clinical and radiographic outcomes in patients undergone all-arthroscopic autologous matrix induced chondrogenesis for symptomatic osteochondral talar lesions

Detailed Description

Not available

Study Timeline

• Study Start: 2016-04-26
• Status Verified: 2017-12
• Study First Submitted: 2017-12-07
• Study First Submitted QC: 2017-12-07
• Last Update Submitted: 2017-12-07
• Study First Posted: 2017-12-13
• Last Update Posted: 2017-12-13
• Primary Completion: 2019-02
• Study Completion: 2028-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 103

Inclusion Criteria

• Age over 18 years
• males and females
• patients underwent arthroscopic cartilage reconstruction surgery with AMIC technique for osteochondral lesions of the talus

Exclusion Criteria

• age <18 years at the time of surgery
• patients with previous surgery on the affected ankle

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Chondro-gide - Geistlich	AT-AMIC (arthroscopic talus autologous matrix induced chondrogenesis)	Arthroscopic use of chondro-gide to treat symptomatic osteochondral talar lesion

Primary Outcome Measures

Name	Time	Method
Radiologic reduction of the lesion	5 years	A reduction of at least 30% of the lesion is to be expected

Trial Locations

Locations (1)

Federico Usuelli; 🇮🇹 Milan, Italy